Author

M. Montoya

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 6

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 5 Organism:human· 4 Approach:biophysical modeling· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2 Approach:statistical model· 2 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

A. de Lucas-Rius· 3 shared J. J. Garrido· 3 shared N. Redondo· 3 shared A. Yamamichi· 2 shared H. Okada· 2 shared P. Chuntova· 2 shared R. Fernandez-Rodriguez· 2 shared T. Garcia-Garcia· 2 shared

Activity by Year

2018-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

A. de Lucas-Rius

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

IRF8-driven reprogramming of the immune microenvironment enhances anti-tumor adaptive immunity and reduces immunosuppression in murine glioblastoma

M. Montoya, S. A. Collins, P. Chuntova, T. S. Patel, T. Nejo, A. Yamamichi, N. Kasahara, H. Okada

This study shows that delivering IRF8 via retroviral vector reprograms myeloid cells in glioblastoma, enhancing anti-tumor immunity and reducing immunosuppression.

bioRxiv · Apr 2, 2024 · PreprintImmunology

Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10

B. D. Lopez-Ayllon, S. Marin, M. Farinas Fernandez, T. Garcia-Garcia, R. Fernandez-Rodriguez, A. de Lucas-Rius, N. Redondo, L. Mendoza-Garcia, C. Foguet, J. Grigas, A. Calvet, J. M. Villalba, M. J. Rodriguez Gomez, D. Megias, B. Mandracchia, , M. Montoya

This study identifies mitochondrial and metabolic reprogramming induced by SARS-CoV-2 accessory proteins in lung cells, revealing potential therapeutic targets.

bioRxiv · Sep 26, 2023Immunology

SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling

B. Dies, A. de Lucas-Rius, L. Mendoza, T. Garcia, R. Fernandez, J. M. Suarez, F. Milhano, F. Corrales, N. Redondo, F. Pedrucci, S. Zaldivar, M. A. Jimenez, M. Montoya, J. J. Garrido

This study identifies SARS-CoV-2 accessory proteins ORF6, ORF8, ORF9b, and ORF9c as contributors to inflammatory and profibrotic responses via IL11 signaling in lung cells.

bioRxiv · Mar 27, 2023Immunology

Antiviral immune responses, cellular metabolism and adhesion are differentially modulated by SARS-CoV-2 ORF7a or ORF7b

T. Garcia-Garcia, R. Fernandez-Rodriguez, N. Redondo, A. de Lucas-Rius, S. Zaldivar-Lopez, B. Dies Lopez-Ayllon, J. M. Suarez-Cardenas, A. Jimenez-Marin, M. Montoya, J. J. Garrido

This study investigates how SARS-CoV-2 ORF7a and ORF7b proteins modulate antiviral responses, metabolism, and adhesion in A549 cells, revealing their role in promoting viral pathogenesis.

bioRxiv · Jun 1, 2022 · PreprintImmunology

Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice

P. Chuntova, Y. Hou, R. Naka, Y. Goretsky, T. Nejo, G. Kohanbash, T. Chen, A. L. Mende, M. Montoya, A. Yamamichi, K. M. Downey, D. Diebold, J. Skinner, H.-E. Liang, B. Schwer, H. Okada

This paper develops a novel transgenic mouse model expressing EGFRvIII-CAR on T-cells to study CAR T-cell therapy in syngeneic glioblastoma models.

bioRxiv · Jan 31, 2021Immunology

Early transcriptional responses after dengue vaccination mirror the response to natural infection and predict neutralizing antibody titers

S. J. Popper, F. R. Strouts, J. C. Lindow, H. K. Cheng, M. Montoya, A. Balmaseda, A. P. Durbin, S. S. Whitehead, E. Harris, B. D. Kirkpatrick, D. A. Relman

bioRxiv · Jul 3, 2018Immunology